Speaker Profile
Biography
Dr. Billy Lau is an Instructor in the Division of Oncology at Stanford University School of Medicine. His research focus is on leveraging genome technology for cancer detection, and for studying human genomic variation. Dr. Lau received his doctorate from Harvard University in Engineering Sciences, and completed his postdoctoral training with Dr. Hanlee Ji at Stanford University. He has also received the NHGRIs Genomic Innovator Award, where he focuses on building tools to maximize information from single molecules and cells.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Stacey Gabriel, Broad Institute and Steve Turner, PacBio
- New Frontiers in Genomic Analysis & Interpretation
- Robert Sebra, ISMMS
- Anshul Kundaje, Stanford
- Chaz Langelier, UCSF
- Orly Alter, Prism AI Inc - From Potential to Reality: Bringing Nanopore Sequencing to Clinical Practice (PANEL)
Chair: Emma Stanton, Oxford Nanopore Tech - Charles Chiu, UCSF
- Billy Tsz Cheong Lau, Stanford - Population Sequencing at Scale: Impact and Future Path of Genomic Programs (PANEL)
Chair: Stacey Gabriel, Broad Institute
- Heidi Rehm, MGH
- Cindy Lawley, Olink
- John M. Gaziano, Million Veterans Program (MVP) - New Frontiers in Genomic Analysis & Interpretation continues: AI in Spatial Transcriptomics in Patient Response
- David. W. Craig, City of Hope Cancer Center
- Premal Shah, MyOme - The Economic Perspective on Genomics (PANEL)
Chair: Bill Hyun, UCSF
- Steve Turner, PacBio
- Alex de Winter, Danaher Ventures
- Kandaswamy (Swamy) Vijayan, Zafrens - Using AI for Scalable Phenotyping and Discovery
- Andrew Carroll, Google
- Building Bridges: Precision Medicine Communities
- Kumar Prashant, Karkinos - NCI Showcase
- Xiaofeng Xie, MicrOmics Technologies